deubiquitinase usp9x suppresses pancreatic ductal adenocarcinoma 
pancreatic ductal adenocarcinoma pda remains lethal malignancy despite much progress concerning molecular characterization pda tumours harbour four signature somatic mutations- addition numerous lower frequency genetic events uncertain significance use sleeping beauty sb transposon-mediated insertional mutagenesis mouse model pancreatic ductal preneoplasia identify genes cooperate oncogenic krasg12d accelerate tumorigenesis promote progression screen revealed new candidate genes pda confirmed importance many genes pathways previously implicated human pda commonly mutated gene x-linked deubiquitinase usp9x inactivated % tumours although previous work attributed pro-survival role usp9x human neoplasia found instead loss usp9x enhances transformation protects pancreatic cancer cells anoikis clinically low usp9x protein messenger rna expression pda correlates poor survival surgery usp9x levels inversely associated metastatic burden advanced disease furthermore chromatin modulation trichostatin aza--deoxycytidine elevates usp9x expression human pda cell lines indicating clinical approach certain patients conditional deletion usp9x cooperated krasg12d accelerate pancreatic tumorigenesis mice validating genetic interaction propose usp9x major tumour suppressor gene prognostic therapeutic relevance pda 
